These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28549592)

  • 1. Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial.
    Lin HW; Lin CH; Chang CK; Chou CY; Yu IW; Lin CC; Li TC; Li CI; Hsieh YW
    J Formos Med Assoc; 2018 Mar; 117(3):235-243. PubMed ID: 28549592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD; Steers N; Adler DS; Kuo GM; Morello CM; Lang M; Singh RF; Wood Y; Kaplan RM; Mangione CM
    Clin Ther; 2014 Sep; 36(9):1244-54. PubMed ID: 25085406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
    Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
    J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative.
    Trygstad TK; Christensen D; Garmise J; Sullivan R; Wegner S
    J Manag Care Pharm; 2005 Sep; 11(7):575-83. PubMed ID: 16137215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect evaluation of an interprofessional medication therapy management approach for multimorbid patients in primary care: a cluster-randomized controlled trial in community care (WestGem study protocol).
    Rose O; Schaffert C; Czarnecki K; Mennemann HS; Waltering I; Hamacher S; Felsch M; Herich L; Köberlein J
    BMC Fam Pract; 2015 Jul; 16():84. PubMed ID: 26198433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
    Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
    J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician attitudes toward pharmacist provision of medication therapy management services.
    Alkhateeb FM; Clauson KA; McCafferty R; Latif DA
    Pharm World Sci; 2009 Aug; 31(4):487-493. PubMed ID: 19472070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tennessee medication therapy management program: A hybrid type 2 effectiveness-implementation trial study protocol.
    Woeppel J; Clark R; Underwood L; Gatwood J; Turner K; Renfro C; Hohmeier KC
    Res Social Adm Pharm; 2020 Mar; 16(3):315-320. PubMed ID: 31151919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.
    Romskaug R; Skovlund E; Straand J; Molden E; Kersten H; Pitkala KH; Lundqvist C; Wyller TB
    JAMA Intern Med; 2020 Feb; 180(2):181-189. PubMed ID: 31617562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy.
    Doucette WR; McDonough RP; Klepser D; McCarthy R
    Clin Ther; 2005 Jul; 27(7):1104-11. PubMed ID: 16154490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.
    Lenander C; Elfsson B; Danielsson B; Midlöv P; Hasselström J
    Scand J Prim Health Care; 2014 Dec; 32(4):180-6. PubMed ID: 25347723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized medication assessment and planning: optimizing medication use in older adults in the primary care setting.
    Roth MT; Ivey JL; Esserman DA; Crisp G; Kurz J; Weinberger M
    Pharmacotherapy; 2013 Aug; 33(8):787-97. PubMed ID: 23722438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
    Smith M; Cannon-Breland ML; Spiggle S
    Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of systematic medication review in elderly patients admitted to an acute ward of internal medicine.
    Lisby M; Thomsen A; Nielsen LP; Lyhne NM; Breum-Leer C; Fredberg U; Jørgensen H; Brock B
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):422-7. PubMed ID: 20059474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing economic burden through split-shared care model for people living with uncontrolled type 2 diabetes and polypharmacy: a multi-center randomized controlled trial.
    Lum ZK; Tan JY; Wong CSM; Kok ZY; Kwek SC; Tsou KYK; Gallagher PJ; Lee JY
    BMC Health Serv Res; 2024 Jun; 24(1):760. PubMed ID: 38907254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the North Carolina long-term care polypharmacy initiative: a multiple-cohort approach using propensity-score matching for both evaluation and targeting.
    Trygstad TK; Christensen DB; Wegner SE; Sullivan R; Garmise JM
    Clin Ther; 2009 Sep; 31(9):2018-37. PubMed ID: 19843492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative DTM reduces hospitalization and healthcare costs in patients with diabetes treated with polypharmacy.
    Brophy L; Williams A; Berman EJ; Keleti D; Michael KE; Shepherd M; Fox SA; Jacobs C; Tan-Torres S; Gelzer AD; Tegenu M
    Am J Manag Care; 2014 Mar; 20(3):e72-81. PubMed ID: 24773329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.